NCT00283335View on ClinicalTrials.gov

The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol

PHASE3CompletedINTERVENTIONAL

Enrollment

2,531

Participants

Timeline

Start Date

June 30, 1991

Primary Completion Date

September 30, 1998

Study Completion Date

August 31, 1999

Conditions

Coronary Heart Disease

Interventions

DRUG

gemfibrozil

OTHER

Placebo

Matching placebo tablets taken once per day

Trial Locations (1)

55417

Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Parke-Davis

INDUSTRY

collaborator

Fournier Labs

UNKNOWN

lead

VA Office of Research and Development

FED